Anti-inflammatory agent 99
Anti-inflammatory agent 99 is a chalcone derivative. Anti-inflammatory agent 99 inhibits LPS (HY-D1056)-induced NF-κB nuclear translocation and suppress the phosphorylation of JNK, ERK, and p38. Anti-inflammatory agent 99 inhibits the expression of cytoinflammatory factors such as TNF-α and IL-6 induced by LPS. Anti-inflammatory agent 99 can be used for the research of LPS-induced septic shock.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1345412-48-7
- Fòrmula: C16H12F2O2
- Peso molecular:274.26
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas TNF Receptor
More
Actividad biológica
|
JNK |
NF-κB |
p38 |
ERK |
IL-6 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RAW264.7 | IC50 |
5.55 μM
Compound: 26
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL6 production incubated for 2 hrs prior to LPS-challenge measured after 22 hrs by ELISA
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL6 production incubated for 2 hrs prior to LPS-challenge measured after 22 hrs by ELISA
|
[PMID: 21988173] |
Anti-inflammatory agent 99 (Compound 26) (2.5-10 μM; 24 h) dose-dependently inhibits LPS-induced TNF-α and IL-6 release in mouse RAW 264.7 macrophages, with IC50 values of 8.42 μM and 5.55 μM, respectively[1].
Anti-inflammatory agent 99 (10 μM; 8 h) inhibits LPS-induced TNF-α, IL-6, IL-1β, and IL-12 mRNA expression in mouse primary peritoneal macrophages, but does not significantly reduce COX-2 mRNA levels[1].
Anti-inflammatory agent 99 (2.5-20 μM; 2.5-3 h) inhibits LPS-induced NF-κB p65 nuclear translocation, and dose-dependently prevents LPS-induced IκB degradation in mouse primary peritoneal macrophages[1].
Anti-inflammatory agent 99 (2.5-20 μM; 2.5 h) dose-dependently inhibits LPS-induced JNK phosphorylation in mouse primary peritoneal macrophages[1].
Anti-inflammatory agent 99 (2.5-20 μM; 3 h) inhibits LPS-induced ERK and p38 phosphorylation, and dose-dependently blocks LPS-induced p38 and ERK activation in mouse primary peritoneal macrophages[1].
Anti-inflammatory agent 99 (10 μM; 5 h) inhibits high Glucose (HY-B0389)-induced TNF-α, IL-1β, IL-6, and IL-12 mRNA expression in mouse primary peritoneal macrophages[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:mouse RAW 264.7 macrophages
-
Concentration:2.5 μM; 5.0 μM; 10 μM
-
Incubation Time:24 h
-
Result:Dose-dependently inhibited LPS-induced TNF-α and IL-6 release.
Exhibited an IC50 of 8.42 μM for TNF-α inhibition and an IC50 of 5.55 μM for IL-6 inhibition.
Significantly reduced TNF-α and IL-6 levels compared to the LPS-only group at 10 μM (p < 0.01).
-
Cell Line:mouse primary peritoneal macrophages
-
Concentration:10 μM
-
Incubation Time:8 h
-
Result:Inhibits LPS-induced TNF-α, IL-6, IL-1β, and IL-12 mRNA expression.
Did not significantly reduce COX-2 mRNA levels.
-
Cell Line:mouse primary peritoneal macrophages
-
Concentration:10 μM
-
Incubation Time:2.5 h
-
Result:Inhibited LPS-induced NF-κB p65 nuclear translocation.
-
Cell Line:mouse primary peritoneal macrophages
-
Concentration:2.5 μM; 5 μM; 10 μM; 20 μM
-
Incubation Time:3 h
-
Result:Dose-dependently inhibited LPS-induced IκB degradation, JNK phosphorylation and activation of p38 and ERK.
Inhibited LPS-induced ERK and p38 phosphorylation at 10 μM.
-
Cell Line:mouse primary peritoneal macrophages
-
Concentration:10 μM
-
Incubation Time:5 h
-
Result:Inhibited high Glucose-induced TNF-α, IL-1β, IL-6, and IL-12 mRNA expression.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (B6) (male, 18−22 g, LPS-induced inflammatory shock model)[1]
-
Dosage:15 mg/kg
-
Administration:i.v.; single dose
-
Result:Exhibited an 80% survival rate over the 7-day observation period.
Showed body weight decrease during the first 60 hours after LPS treatment that regained slowly afterward.
Chemical Information
-
No. CAS 1345412-48-7
-
Peso molecular 274.26
-
Fòrmula C16H12F2O2
-
SMILES
O=C(C1=CC=C(C=C1)OC)/C=C/C2=C(C=CC=C2F)F
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anti-inflammatory agent 99 Related Classifications
HY-183934 Related Classifications
Powered by Bioz